Glycosylated porphyrin-cucurbituril conjugate for photodynamic inactivation of bacteria and doxorubicin carriage for anticancer drug delivery

buir.contributor.authorÖzkan, Melis
buir.contributor.authorKeser, Yağmur
buir.contributor.authorKoç, Ahmet
buir.contributor.authorTuncel, Dönüş
dc.citation.epage1413en_US
dc.citation.issueNumber11en_US
dc.citation.spage1406en_US
dc.citation.volumeNumber23en_US
dc.contributor.authorÖzkan, Melisen_US
dc.contributor.authorKeser, Yağmuren_US
dc.contributor.authorKoç, Ahmeten_US
dc.contributor.authorTuncel, Dönüşen_US
dc.date.accessioned2020-02-24T13:50:49Z
dc.date.available2020-02-24T13:50:49Z
dc.date.issued2019-10
dc.departmentDepartment of Chemistryen_US
dc.departmentInstitute of Materials Science and Nanotechnology (UNAM)en_US
dc.description.abstractPorphyrin derivatives are highly attractive in the construction of multifunctional molecular platforms with interesting properties and applications. In this regard, we report here the use of a multifunctional porphyrin-based molecular platform as a photosensitizer for photodynamic therapy and as a drug carrier. This molecular platform was constructed by conjugating a host molecule, cucurbit[7]uril to a triglycosylated tetraphenyl porphyrin and serves very efficiently as a photosensitizer in the inactivation of both gram-negative (Escherichia coli, E. coli) and gram-positive bacteria (Bacillus subtilis, B. subtilis) and growth inhibition of cancer cells as well as a doxorubicin (DOX) carrier for chemo-photodynamic dual cancer therapy. Another remarkable feature of this photosensitizer is that it shows negligible cytotoxicity in the dark.en_US
dc.description.provenanceSubmitted by Evrim Ergin (eergin@bilkent.edu.tr) on 2020-02-24T13:50:49Z No. of bitstreams: 1 Glycosylated_porphyrin-cucurbituril_conjugate_for_photodynamic_inactivation_of_bacteria_and_doxorubicin_carriage_for_anticancer_drug_delivery.pdf: 433578 bytes, checksum: 7c6e1485ceb96b78b9f317b75420410c (MD5)en
dc.description.provenanceMade available in DSpace on 2020-02-24T13:50:49Z (GMT). No. of bitstreams: 1 Glycosylated_porphyrin-cucurbituril_conjugate_for_photodynamic_inactivation_of_bacteria_and_doxorubicin_carriage_for_anticancer_drug_delivery.pdf: 433578 bytes, checksum: 7c6e1485ceb96b78b9f317b75420410c (MD5) Previous issue date: 2019-10en
dc.identifier.doi10.1142/S1088424619501578en_US
dc.identifier.issn1088-4246
dc.identifier.urihttp://hdl.handle.net/11693/53487
dc.language.isoEnglishen_US
dc.publisherWorld Scientific Publishingen_US
dc.relation.isversionofhttps://dx.doi.org/10.1142/S1088424619501578en_US
dc.source.titleJournal of Porphyrins and Phthalocyaninesen_US
dc.subjectPorphyrinen_US
dc.subjectCucurbiturilen_US
dc.subjectMulti-functional molecular platformen_US
dc.subjectLight-activated antimicrobial agenten_US
dc.subjectPhotodynamic effecten_US
dc.subjectDoxorubicin deliveryen_US
dc.subjectAnticancer therapyen_US
dc.titleGlycosylated porphyrin-cucurbituril conjugate for photodynamic inactivation of bacteria and doxorubicin carriage for anticancer drug deliveryen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Glycosylated_porphyrin-cucurbituril_conjugate_for_photodynamic_inactivation_of_bacteria_and_doxorubicin_carriage_for_anticancer_drug_delivery.pdf
Size:
457.44 KB
Format:
Adobe Portable Document Format
Description: